Conceptio › Archive › Repisalud
Repisaludmetadata only

RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1.

de-la-Puente-Ovejero, Laura et al.
Repisalud · Other
Open Source ↗
k-ras oncogene, a-raf, b-raf, protein-kinase, apoptosis, mice, regression, mutations
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 251519
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.